Similarly, a higher frequency of AURKA amplification, a key regulator of the mitotic cell division process, has been reported in tumors from BRCA-mutated female BC cases compared to non-mutated cases, suggesting a possible cooperation between AURKA overexpression and BRCA inactivation in tumor development and progression [28]. The gene discussed is AURKA; the disease is neoplasm.